-
1
-
-
34548042964
-
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel
-
DOI 10.1182/blood-2007-04-083501
-
Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110(4):1092-1097. (Pubitemid 47281402)
-
(2007)
Blood
, vol.110
, Issue.4
, pp. 1092-1097
-
-
Tefferi, A.1
Thiele, J.2
Orazi, A.3
Kvasnicka, H.M.4
Barbui, T.5
Hanson, C.A.6
Barosi, G.7
Verstovsek, S.8
Birgegard, G.9
Mesa, R.10
Reilly, J.T.11
Gisslinger, H.12
Vannucchi, A.M.13
Cervantes, F.14
Finazzi, G.15
Hoffman, R.16
Gilliland, D.G.17
Bloomfield, C.D.18
Vardiman, J.W.19
-
2
-
-
8344229870
-
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
-
DOI 10.1016/j.amjmed.2004.06.032, PII S0002934304005315
-
Passamonti F, Rumi E, Pungolino E, et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med. 2004;117(10):755-761. (Pubitemid 39482529)
-
(2004)
American Journal of Medicine
, vol.117
, Issue.10
, pp. 755-761
-
-
Passamonti, F.1
Rumi, E.2
Pungolino, E.3
Malabarba, L.4
Bertazzoni, P.5
Valentini, M.6
Orlandi, E.7
Arcaini, L.8
Brusamolino, E.9
Pascutto, C.10
Cazzola, M.11
Morra, E.12
Lazzarino, M.13
-
3
-
-
32144461605
-
Essential thrombocythemia beyond the first decade: Life expectancy, long-term complication rates, and prognostic factors
-
Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc. 2006;81(2):159-166. (Pubitemid 43205767)
-
(2006)
Mayo Clinic Proceedings
, vol.81
, Issue.2
, pp. 159-166
-
-
Wolanskyj, A.P.1
Schwager, S.M.2
McClure, R.F.3
Larson, D.R.4
Tefferi, A.5
-
4
-
-
0022703490
-
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols
-
Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI,Wasserman LR. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol. 1986;23(2):132-143.
-
(1986)
Semin Hematol
, vol.23
, Issue.2
, pp. 132-143
-
-
Berk, P.D.1
Goldberg, J.D.2
Donovan, P.B.3
Fruchtman, S.M.4
Berlin, N.I.5
Wasserman, L.R.6
-
5
-
-
38049188368
-
Bone marrow pathology in essential thrombocythemia: Interobserver reliability and utility for identifying disease subtypes
-
Wilkins BS, Erber WN, Bareford D, et al. Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. Blood. 2008;111(1):60-70.
-
(2008)
Blood
, vol.111
, Issue.1
, pp. 60-70
-
-
Wilkins, B.S.1
Erber, W.N.2
Bareford, D.3
-
6
-
-
79957611312
-
Essential thrombocythemia versus early primary myelofibrosis: A multicenter study to validate the WHO classification
-
Thiele J, Kvasnicka HM, Mullauer L, Buxhofer-Ausch V, Gisslinger B, Gisslinger H. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. Blood. 2011;117(21):5710-5718.
-
(2011)
Blood
, vol.117
, Issue.21
, pp. 5710-5718
-
-
Thiele, J.1
Kvasnicka, H.M.2
Mullauer, L.3
Buxhofer-Ausch, V.4
Gisslinger, B.5
Gisslinger, H.6
-
7
-
-
80051803115
-
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: An international study
-
Barbui T, Thiele J, Passamonti F, et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol. 2011;29(23):3179-3184.
-
(2011)
J Clin Oncol
, vol.29
, Issue.23
, pp. 3179-3184
-
-
Barbui, T.1
Thiele, J.2
Passamonti, F.3
-
8
-
-
43949103121
-
Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders
-
DOI 10.1038/leu.2008.72, PII LEU200872
-
Cervantes F, Passamonti F, Barosi G. Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders. Leukemia. 2008;22(5):905-914. (Pubitemid 351698623)
-
(2008)
Leukemia
, vol.22
, Issue.5
, pp. 905-914
-
-
Cervantes, F.1
Passamonti, F.2
Barosi, G.3
-
9
-
-
79551491928
-
Philadelphia-negative classical myeloproliferative neoplasms: Critical concepts and management recommendations from European LeukemiaNet
-
Barbui T, Barosi G, Birgegard G, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol. 2011;29(6):761-770.
-
(2011)
J Clin Oncol
, vol.29
, Issue.6
, pp. 761-770
-
-
Barbui, T.1
Barosi, G.2
Birgegard, G.3
-
10
-
-
79960238893
-
Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: A retrospective study
-
Palandri F, Polverelli N, Catani L, Ottaviani E, Baccarani M, Vianelli N. Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study. Ann Hematol. 2011;90(8):933-938.
-
(2011)
Ann Hematol
, vol.90
, Issue.8
, pp. 933-938
-
-
Palandri, F.1
Polverelli, N.2
Catani, L.3
Ottaviani, E.4
Baccarani, M.5
Vianelli, N.6
-
11
-
-
77950945887
-
Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: A population-based study of 311 patients
-
Girodon F, Dutrillaux F, Broseus J, et al. Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients. Leukemia. 2010;24(4):900-903.
-
(2010)
Leukemia
, vol.24
, Issue.4
, pp. 900-903
-
-
Girodon, F.1
Dutrillaux, F.2
Broseus, J.3
-
12
-
-
33846540216
-
Risk stratification for survival and leukemic transformation in essential thrombocythemia: A single institutional study of 605 patients
-
DOI 10.1038/sj.leu.2404500, PII 2404500
-
Gangat N, Wolanskyj AP, McClure RF, et al. Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients. Leukemia. 2007;21(2):270-276. (Pubitemid 46158119)
-
(2007)
Leukemia
, vol.21
, Issue.2
, pp. 270-276
-
-
Gangat, N.1
Wolanskyj, A.P.2
McClure, R.F.3
Li, C.-Y.4
Schwager, S.5
Wu, W.6
Tefferi, A.7
-
13
-
-
39149105615
-
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A consensus statement from the international working group for myelofibrosis research and treatment [6]
-
DOI 10.1038/sj.leu.2404914, PII 2404914
-
Barosi G, Mesa RA, Thiele J, et al. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment. Leukemia. 2008;22(2):437-438. (Pubitemid 351250553)
-
(2008)
Leukemia
, vol.22
, Issue.2
, pp. 437-438
-
-
Barosi, G.1
Mesa, R.A.2
Thiele, J.3
Cervantes, F.4
Campbell, P.J.5
Verstovsek, S.6
Dupriez, B.7
Levine, R.L.8
Passamonti, F.9
Gotlib, J.10
Reilly, J.T.11
Vannucchi, A.M.12
Hanson, C.A.13
Solberg, L.A.14
Orazi, A.15
Tefferi, A.16
-
15
-
-
79957975519
-
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients
-
Carobbio A, Thiele J, Passamonti F, et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood. 2011;117(22):5857-5859.
-
(2011)
Blood
, vol.117
, Issue.22
, pp. 5857-5859
-
-
Carobbio, A.1
Thiele, J.2
Passamonti, F.3
-
16
-
-
66749172267
-
Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: A population-based study
-
Girodon F, Bonicelli G, Schaeffer C, et al. Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study. Haematologica. 2009;94(6):865-869.
-
(2009)
Haematologica
, vol.94
, Issue.6
, pp. 865-869
-
-
Girodon, F.1
Bonicelli, G.2
Schaeffer, C.3
-
17
-
-
33947262701
-
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: Interaction with treatment, standard risk factors, and Jak2 mutation status
-
DOI 10.1182/blood-2006-09-046342
-
Carobbio A, Finazzi G, Guerini V, et al. Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. Blood. 2007;109(6):2310-2313. (Pubitemid 46425868)
-
(2007)
Blood
, vol.109
, Issue.6
, pp. 2310-2313
-
-
Carobbio, A.1
Finazzi, G.2
Guerini, V.3
Spinelli, O.4
Delaini, F.5
Marchioli, R.6
Borrelli, G.7
Rambaldi, A.8
Barbui, T.9
-
18
-
-
54049086618
-
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
-
Carobbio A, Finazzi G, Antonioli E, et al. Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia. Blood. 2008;112(8):3135-3137.
-
(2008)
Blood
, vol.112
, Issue.8
, pp. 3135-3137
-
-
Carobbio, A.1
Finazzi, G.2
Antonioli, E.3
-
19
-
-
45749098579
-
Leukocytosis and risk stratification assessment in essential thrombocythemia
-
Carobbio A, Antonioli E, Guglielmelli P, et al. Leukocytosis and risk stratification assessment in essential thrombocythemia. J Clin Oncol. 2008;26(16):2732-2736.
-
(2008)
J Clin Oncol
, vol.26
, Issue.16
, pp. 2732-2736
-
-
Carobbio, A.1
Antonioli, E.2
Guglielmelli, P.3
-
20
-
-
69249223035
-
Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms
-
Caramazza D, Caracciolo C, Barone R, et al. Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms. Ann Hematol. 2009;88(10):967-971.
-
(2009)
Ann Hematol
, vol.88
, Issue.10
, pp. 967-971
-
-
Caramazza, D.1
Caracciolo, C.2
Barone, R.3
-
21
-
-
55549099571
-
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: A study of 605 patients
-
Passamonti F, Rumi E, Arcaini L, et al. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients. Haematologica. 2008;93(11):1645-1651.
-
(2008)
Haematologica
, vol.93
, Issue.11
, pp. 1645-1651
-
-
Passamonti, F.1
Rumi, E.2
Arcaini, L.3
-
22
-
-
73149090129
-
Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera
-
Gangat N, Wolanskyj AP, Schwager SM, Hanson CA, Tefferi A. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera. Cancer. 2009;115(24):5740-5745.
-
(2009)
Cancer
, vol.115
, Issue.24
, pp. 5740-5745
-
-
Gangat, N.1
Wolanskyj, A.P.2
Schwager, S.M.3
Hanson, C.A.4
Tefferi, A.5
-
23
-
-
69249217916
-
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia
-
Passamonti F, Rumi E, Pascutto C, Cazzola M, Lazzarino M. Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia. J Thromb Haemost. 2009;7(9):1587-1589.
-
(2009)
J Thromb Haemost
, vol.7
, Issue.9
, pp. 1587-1589
-
-
Passamonti, F.1
Rumi, E.2
Pascutto, C.3
Cazzola, M.4
Lazzarino, M.5
-
24
-
-
55049131023
-
Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia
-
Dahabreh IJ, Zoi K, Giannouli S, Zoi C, Loukopoulos D, Voulgarelis M. Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia. Leuk Res. 2009;33(1):67-73.
-
(2009)
Leuk Res
, vol.33
, Issue.1
, pp. 67-73
-
-
Dahabreh, I.J.1
Zoi, K.2
Giannouli, S.3
Zoi, C.4
Loukopoulos, D.5
Voulgarelis, M.6
-
25
-
-
68549116852
-
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
-
Lussana F, Caberlon S, Pagani C, Kamphuisen PW, Buller HR, Cattaneo M. Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review. Thromb Res. 2009;124(4):409-417.
-
(2009)
Thromb Res
, vol.124
, Issue.4
, pp. 409-417
-
-
Lussana, F.1
Caberlon, S.2
Pagani, C.3
Kamphuisen, P.W.4
Buller, H.R.5
Cattaneo, M.6
-
26
-
-
80555154949
-
Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies
-
Passamonti F, Maffioli M, Caramazza D, Cazzola M. Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies. Oncotarget. 2011;2(6):485-490.
-
(2011)
Oncotarget
, vol.2
, Issue.6
, pp. 485-490
-
-
Passamonti, F.1
Maffioli, M.2
Caramazza, D.3
Cazzola, M.4
-
27
-
-
78651344350
-
Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: A single center study of 433 patients
-
Caramazza D, Begna KH, Gangat N, et al. Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients. Leukemia. 2011;25(1):82-88.
-
(2011)
Leukemia
, vol.25
, Issue.1
, pp. 82-88
-
-
Caramazza, D.1
Begna, K.H.2
Gangat, N.3
|